Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$25.89 - $29.73 $201,475 - $231,358
7,782 Added 5.77%
142,753 $3.96 Million
Q4 2023

Feb 06, 2024

SELL
$26.13 - $33.94 $156,989 - $203,911
-6,008 Reduced 4.26%
134,971 $3.89 Million
Q3 2023

Nov 03, 2023

BUY
$32.09 - $37.51 $516,969 - $604,286
16,110 Added 12.9%
140,979 $4.68 Million
Q2 2023

Aug 04, 2023

BUY
$36.12 - $41.79 $114,897 - $132,933
3,181 Added 2.61%
124,869 $4.58 Million
Q1 2023

May 01, 2023

BUY
$39.39 - $51.28 $41,792 - $54,408
1,061 Added 0.88%
121,688 $4.96 Million
Q4 2022

Feb 07, 2023

SELL
$41.75 - $54.5 $153,765 - $200,723
-3,683 Reduced 2.96%
120,627 $6.18 Million
Q3 2022

Nov 03, 2022

SELL
$43.76 - $53.42 $95,878 - $117,043
-2,191 Reduced 1.73%
124,310 $5.44 Million
Q2 2022

Aug 02, 2022

SELL
$46.53 - $55.17 $103,761 - $123,029
-2,230 Reduced 1.73%
126,501 $6.63 Million
Q1 2022

May 09, 2022

BUY
$45.75 - $56.69 $242,109 - $300,003
5,292 Added 4.29%
128,731 $6.67 Million
Q4 2021

Jan 26, 2022

BUY
$41.32 - $61.25 $167,883 - $248,858
4,063 Added 3.4%
123,439 $7.29 Million
Q3 2021

Nov 05, 2021

BUY
$39.25 - $50.42 $151,622 - $194,772
3,863 Added 3.34%
119,376 $5.14 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $186,157 - $210,885
5,184 Added 4.7%
115,513 $4.52 Million
Q1 2021

May 10, 2021

SELL
$33.49 - $37.77 $130,945 - $147,680
-3,910 Reduced 3.42%
110,329 $4 Million
Q4 2020

Feb 05, 2021

BUY
$33.47 - $42.56 $400,937 - $509,826
11,979 Added 11.71%
114,239 $4.21 Million
Q3 2020

Nov 09, 2020

BUY
$31.75 - $37.25 $270,891 - $317,817
8,532 Added 9.1%
102,260 $3.75 Million
Q2 2020

Jul 31, 2020

BUY
$30.12 - $36.54 $342,825 - $415,898
11,382 Added 13.82%
93,728 $3.07 Million
Q1 2020

Apr 24, 2020

BUY
$27.03 - $38.62 $173,586 - $248,017
6,422 Added 8.46%
82,346 $2.69 Million
Q4 2019

Feb 07, 2020

BUY
$32.92 - $37.36 $85,098 - $96,575
2,585 Added 3.52%
75,924 $2.98 Million
Q3 2019

Nov 06, 2019

BUY
$32.49 - $42.13 $303,846 - $393,999
9,352 Added 14.62%
73,339 $2.64 Million
Q2 2019

Aug 06, 2019

BUY
$36.98 - $41.52 $486,360 - $546,071
13,152 Added 25.87%
63,987 $2.77 Million
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $184,950 - $203,198
4,932 Added 10.74%
50,835 $2.16 Million
Q4 2018

Feb 08, 2019

BUY
$38.47 - $43.86 $103,599 - $118,114
2,693 Added 6.23%
45,903 $2 Million
Q3 2018

Nov 06, 2018

SELL
$34.47 - $41.81 $124,264 - $150,725
-3,605 Reduced 7.7%
43,210 $1.9 Million
Q2 2018

Aug 08, 2018

SELL
$32.98 - $35.16 $125,686 - $133,994
-3,811 Reduced 7.53%
46,815 $1.7 Million
Q1 2018

May 09, 2018

SELL
$31.91 - $37.02 $1.38 Million - $1.6 Million
-43,300 Reduced 46.1%
50,626 $1.8 Million
Q4 2017

Feb 13, 2018

BUY
$33.26 - $35.29 $1.11 Million - $1.18 Million
33,493 Added 55.42%
93,926 $3.4 Million
Q3 2017

Oct 31, 2017

BUY
$31.0 - $34.15 $35,557 - $39,170
1,147 Added 1.93%
60,433 $2.16 Million
Q2 2017

Aug 07, 2017

BUY
N/A
59,286
59,286 $1.99 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Lincoln National Corp Portfolio

Follow Lincoln National Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln National Corp with notifications on news.